Bank of Montreal’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding IDNA
WBG
PGA
Bank of Montreal's IDNA Position: Q4 2025 in Review
Bank of Montreal sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q4 2025, closing a stake of 780 shares — an estimated $18.4K sold.
Bank of Montreal first reported a position in IDNA in Q3 2020 and held it in 19 quarters. The position peaked at $147K in Q3 2021. 58 funds tracked by Wall St. Rank hold IDNA as of Q4 2025.
- Bank of Montreal reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q4 2025 after selling out during the quarter.
- Bank of Montreal sold 780 iShares Genomics Immunology and Healthcare ETF shares in Q4 2025, an estimated $18.4K.
- Bank of Montreal first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and held it in 19 quarters.
- Bank of Montreal's iShares Genomics Immunology and Healthcare ETF position peaked at $147K in Q3 2021.
- 58 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2025.
Based on Bank of Montreal's 13F filing for Q4 2025, filed 12 Feb 2026.